Comment on: “$ Levothyrox^{®} $ New and Old Formulations: Are they Switchable for Millions of Patients?”
| Medienart: |
Artikel |
|---|
| Erscheinungsjahr: |
2019 |
|---|---|
| Erschienen: |
2019 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:58 |
|---|---|
| Enthalten in: |
Clinical pharmacokinetics - 58(2019), 7 vom: 03. Juni, Seite 965-966 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Coste, Joël [VerfasserIn] |
|---|
| Links: |
Volltext [lizenzpflichtig] |
|---|
| RVK: |
|---|
| Anmerkungen: |
© Springer Nature Switzerland AG 2019 |
|---|
| doi: |
10.1007/s40262-019-00779-9 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
OLC2037637993 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | OLC2037637993 | ||
| 003 | DE-627 | ||
| 005 | 20230514000959.0 | ||
| 007 | tu | ||
| 008 | 200819s2019 xx ||||| 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s40262-019-00779-9 |2 doi | |
| 035 | |a (DE-627)OLC2037637993 | ||
| 035 | |a (DE-He213)s40262-019-00779-9-p | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 610 |q VZ |
| 084 | |a 15,3 |2 ssgn | ||
| 084 | |a PHARM |q DE-84 |2 fid | ||
| 084 | |a XA 36894 |q VZ |2 rvk | ||
| 100 | 1 | |a Coste, Joël |e verfasserin |0 (orcid)0000-0001-7674-7192 |4 aut | |
| 245 | 1 | 0 | |a Comment on: “$ Levothyrox^{®} $ New and Old Formulations: Are they Switchable for Millions of Patients?” |
| 264 | 1 | |c 2019 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 500 | |a © Springer Nature Switzerland AG 2019 | ||
| 700 | 1 | |a Bertagna, Xavier |4 aut | |
| 700 | 1 | |a Zureik, Mahmoud |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Clinical pharmacokinetics |d Springer International Publishing, 1976 |g 58(2019), 7 vom: 03. Juni, Seite 965-966 |w (DE-627)129450995 |w (DE-600)197627-8 |w (DE-576)014816253 |x 0312-5963 |7 nnns |
| 773 | 1 | 8 | |g volume:58 |g year:2019 |g number:7 |g day:03 |g month:06 |g pages:965-966 |
| 856 | 4 | 1 | |u https://doi.org/10.1007/s40262-019-00779-9 |z lizenzpflichtig |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a SYSFLAG_A | ||
| 912 | |a GBV_OLC | ||
| 912 | |a FID-PHARM | ||
| 912 | |a SSG-OLC-PHA | ||
| 912 | |a SSG-OLC-DE-84 | ||
| 912 | |a SSG-OPC-PHA | ||
| 912 | |a GBV_ILN_4219 | ||
| 936 | r | v | |a XA 36894 |
| 951 | |a AR | ||
| 952 | |d 58 |j 2019 |e 7 |b 03 |c 06 |h 965-966 | ||